Novartis has taken up its option to license antisense oligonucleotide TQJ230, triggering a $150 mill
Read More
Incyte’s Hiroomi Tada joined as chief medical officer, while Aquinox’s Lloyd Mackenzie will serve as
Read More
Shares of Alameda, Calif.-based Exelixis are climbing after the U.S. Food and Drug Administration (F
Read More
The notorious legacy of OxyContin continues to be a major black mark against Purdue Pharma. And that
Read More
The government-backed National Institute of Health Research (NIHR) awarded the money to researchers
Read More
Just weeks after Sun Pharma’s stock was hit by whistleblower allegations of insider trading, a secon
Read More
Researchers with American University have identified genetic factors that lead to squamous cell carc
Read More